180生命科学宣布定价290万美元注册直接发行

2024-12-27 22:24

180 Life Sciences (NASDAQ:ATNF) entered into a securities purchase agreement with several institutional investors to sell 1.2M shares of common stock in a registered direct offering priced at market under Nasdaq rules.
In a concurrent private placement, the company also agreed to issue unregistered warrants to purchase up to an aggregate of 1,200,000 shares of common stock.
The combined effective offering price for each share of common stock and accompanying warrants is $2.41.
The warrants will have an exercise price of $2.28 per share, will be exercisable immediately, and expire on the five and a half year anniversary from the date of issuance.
The gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $2.9 million.
Source: Press Release

More on 180 Life Sciences